These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35708912)

  • 1. Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor-immunosuppressive phenotype.
    Porter RL; Sun S; Flores MN; Berzolla E; You E; Phillips IE; Kc N; Desai N; Tai EC; Szabolcs A; Lang ER; Pankaj A; Raabe MJ; Thapar V; Xu KH; Nieman LT; Rabe DC; Kolin DL; Stover EH; Pepin D; Stott SL; Deshpande V; Liu JF; Solovyov A; Matulonis UA; Greenbaum BD; Ting DT
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35708912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Extracellular Vesicles in Epithelial Ovarian Cancer: A Systematic Review.
    Lucidi A; Buca D; Ronsini C; Tinari S; Bologna G; Buca D; Leombroni M; Liberati M; D'Antonio F; Scambia G; Lanuti P; Petrillo M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
    Yue H; Li W; Chen R; Wang J; Lu X; Li J
    Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing.
    Iwata T; Kishikawa T; Seimiya T; Notoya G; Suzuki T; Shibata C; Miyakawa Y; Odawara N; Funato K; Tanaka E; Yamagami M; Sekiba K; Otsuka M; Koike K; Fujishiro M
    J Biol Chem; 2024 Mar; 300(3):105742. PubMed ID: 38346537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking satellite silence: human satellite II RNA expression in ovarian cancer.
    Ganesan S
    J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35968784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of miRNA-lncRNA-mRNA co-expression network affecting EMT-mediated cisplatin resistance in ovarian cancer.
    Naghsh-Nilchi A; Ebrahimi Ghahnavieh L; Dehghanian F
    J Cell Mol Med; 2022 Aug; 26(16):4530-4547. PubMed ID: 35810383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition.
    Lin X; Tang X; Zheng T; Qiu J; Hua K
    J Ovarian Res; 2020 Apr; 13(1):45. PubMed ID: 32334623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
    Harrington BS; Kamdar R; Ning F; Korrapati S; Caminear MW; Hernandez LF; Butcher D; Edmondson EF; Traficante N; Hendley J; ; Gough M; Rogers R; Lourie R; Shetty J; Tran B; Elloumi F; Abdelmaksoud A; Nag ML; Mazan-Mamczarz K; House CD; Hooper JD; Annunziata CM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):270. PubMed ID: 37858159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL; Fan MH; Dlamini N; Liu CL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.
    Gao L; Nie X; Gou R; Hu Y; Dong H; Li X; Lin B
    J Cell Mol Med; 2021 Dec; 25(23):10916-10929. PubMed ID: 34725902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 17. SMAD3 inducing the transcription of  STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
    Shi Y; Zhang J; Liu M; Huang Y; Yin L
    J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
    Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis.
    Fan H; Atiya HI; Wang Y; Pisanic TR; Wang TH; Shih IM; Foy KK; Frisbie L; Buckanovich RJ; Chomiak AA; Tiedemann RL; Rothbart SB; Chandler C; Shen H; Coffman LG
    Cell Rep; 2020 Dec; 33(10):108473. PubMed ID: 33296650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad7 maintains epithelial phenotype of ovarian cancer stem-like cells and supports tumor colonization by mesenchymal-epithelial transition.
    Li Y; Gong W; Ma X; Sun X; Jiang H; Chen T
    Mol Med Rep; 2015 Jan; 11(1):309-16. PubMed ID: 25333457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.